"Broadlawns Medical Center has served as Polk County’s safety net hospital since 1924. Broadlawns is dedicated to ensuring that high quality healthcare is accessible and affordable for everyone in the community. The Broadlawns campus includes an acute care hospital, primary and specialty care clinics, urgent care and emergency services, lab, radiology, dentistry, crisis services, inpatient, outpatient and community-based mental healthcare. Broadlawns accepts all forms of insurance."

During the past decade, Broadlawns Medical Center conducted 125 clinical trials. In the 10-year time frame, 125 clinical trials started and 22 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 22 clinical trials were completed. i.e. 46.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Broadlawns Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Broadlawns Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 76 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Broadlawns Medical Center" are "Invasive Breast Carcinoma" (7 trials), "Stage IIIB Lung Cancer AJCC v8" (6 trials), "Metastatic Malignant Neoplasm in the Brain" (5 trials), "Plasma Cell Myeloma" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (5 trials). Many other conditions were trialed in "Broadlawns Medical Center" in a lesser frequency.

Most popular intervention types in "Broadlawns Medical Center" are "Drug" (108 trials), "Other" (82 trials), "Biological" (56 trials), "Procedure" (50 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (41 trials), "Questionnaire Administration" (36 trials), "Biospecimen Collection" (26 trials), "Computed Tomography" (26 trials) and "Nivolumab" (25 trials). Other intervention names were less common.

The vast majority of trials in "Broadlawns Medical Center" are 125 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Broadlawns Medical Center". undefined are not yet recruiting, 68 are recruiting, 54 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Broadlawns Medical Center, 5 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Broadlawns Medical Center, 2 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".